ARS Pharmaceuticals
SPRY
#4845
Rank
ยฃ1.04 B
Marketcap
ยฃ10.69
Share price
-2.80%
Change (1 day)
61.22%
Change (1 year)

Revenue for ARS Pharmaceuticals (SPRY)

Revenue in 2024 (TTM): ยฃ70.93 Million

According to ARS Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is ยฃ66.96 Million. an increase over the revenue in the year 2023 that were of ยฃ0.02 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for ARS Pharmaceuticals from 2022 to 2024

Annual revenue

Year Revenue Change
2024 ยฃ71.04 M301584.03%
2023 ยฃ0.02 M-97.84%
2022 ยฃ1.08 M